GCP
XENT

GSA Capital Partners’s Intersect ENT, Inc XENT Stock Holding History

GSA Capital Partners’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,013
Closed -$364K – 1969
2022
Q1 		$364K Buy
+13,013
New +$357K 0.05% 754
2020
Q4 		– Sell
-27,171
Closed -$443K – 1735
2020
Q3 		$443K Buy
+27,171
New +$492K 0.07% 469
2019
Q1 		– Sell
-17,651
Closed -$497K – 1782
2018
Q4 		$497K Sell
17,651
-9,433
-35% -$276K 0.06% 566
2018
Q3 		$779K Sell
27,084
-8,596
-24% -$258K 0.04% 831
2018
Q2 		$1.34M Buy
35,680
+29,989
+527% +$1.18M 0.07% 551
2018
Q1 		$224K Sell
5,691
-41,215
-88% -$1.51M 0.01% 1432
2017
Q4 		$1.52M Buy
46,906
+17,172
+58% +$515K 0.09% 349
2017
Q3 		$926K Buy
+29,734
New +$880K 0.06% 578

GSA Capital Partners's XENT Position: Q2 2022 in Review

GSA Capital Partners sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 13,013 shares — an estimated $364K sold.

GSA Capital Partners first reported a position in XENT in Q3 2017 and held it in 8 quarters. The position peaked at $1.52M in Q4 2017. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • GSA Capital Partners reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • GSA Capital Partners sold 13,013 Intersect ENT, Inc shares in Q2 2022, an estimated $364K.
  • GSA Capital Partners first reported a position in Intersect ENT, Inc in Q3 2017 and held it in 8 quarters.
  • GSA Capital Partners's Intersect ENT, Inc position peaked at $1.52M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.